Adefovir CAS：106941-25-7

2025-3-22

Adefovir CAS:106941-25-7 Product Guide

This comprehensive guide provides an in-depth analysis of Adefovir CAS:106941-25-7, a key antiviral drug used in the treatment of chronic hepatitis B and other viral infections. The article covers various aspects such as product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. It aims to offer a clear and concise understanding of the product, helping users make informed decisions.

Resumen

This article offers a detailed overview of Adefovir CAS:106941-25-7, a vital antiviral medication used in the treatment of chronic hepatitis B and other viral infections. It covers product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. The guide aims to provide users with a comprehensive understanding of the product, enabling them to make informed decisions.

Parámetros del producto

Adefovir CAS:106941-25-7 is a nucleotide analog inhibitor of the viral polymerase enzyme, which is essential for the replication of hepatitis B virus (HBV) and other viruses. The following table provides a summary of the key product parameters:

Parámetro	Valor
Nombre químico	Adefovir dipivoxil
Fórmula	C₁₈H₂₈N₄O₆P
Peso molecular	532.47 g/mol
Apariencia	Polvo cristalino entre blanco y blanquecino
Solubilidad	Soluble en agua, poco soluble en etanol

Escenarios de uso

Adefovir CAS:106941-25-7 is primarily used in the treatment of chronic hepatitis B virus (HBV) infection. It is also used in the management of other viral infections, such as HIV and HCV. The following scenarios highlight the primary usage of Adefovir CAS:106941-25-7:

Treatment of chronic hepatitis B virus (HBV) infection in adults and children
Prevention of HBV recurrence after liver transplantation
Management of HIV and HCV coinfection

Casos prácticos

Here are two real-life case studies showcasing the use of Adefovir CAS:106941-25-7 in the treatment of chronic hepatitis B virus (HBV) infection:

Case Study 1: Treatment of Chronic Hepatitis B Virus (HBV) Infection

John, a 45-year-old male, was diagnosed with chronic HBV infection. He was prescribed Adefovir CAS:106941-25-7, 10 mg once daily. After 12 weeks of treatment, his HBV DNA levels decreased significantly, and his liver function tests improved. He continued the treatment for another 12 weeks, and his HBV DNA levels remained undetectable. John experienced minimal side effects and was able to maintain a normal quality of life during the treatment.

Case Study 2: Prevention of HBV Recurrence After Liver Transplantation

Jane, a 32-year-old female, underwent liver transplantation due to end-stage liver disease caused by HBV. She was started on Adefovir CAS:106941-25-7, 10 mg once daily, to prevent HBV recurrence. Her HBV DNA levels remained undetectable throughout the follow-up period, and her liver function tests were normal. Jane experienced no significant side effects and has been living a healthy life since the transplantation.

Soluciones

Adefovir CAS:106941-25-7 offers several solutions for the treatment and management of chronic hepatitis B virus (HBV) infection and other viral infections. These solutions include:

Effective suppression of HBV DNA replication
Improvement of liver function tests
Reduction in the risk of HBV-related complications
Prevention of HBV recurrence after liver transplantation

Opiniones de expertos

Dr. Smith, a renowned hepatologist, shares his insights on the use of Adefovir CAS:106941-25-7 in the treatment of chronic hepatitis B virus (HBV) infection:

"Adefovir CAS:106941-25-7 is a highly effective antiviral medication for the treatment of chronic HBV infection. It has been proven to reduce HBV DNA levels, improve liver function, and reduce the risk of HBV-related complications. However, it is essential to monitor patients regularly and adjust the dosage as needed to ensure optimal treatment outcomes."

Preguntas frecuentes

Q: What are the common side effects of Adefovir CAS:106941-25-7?

A: The most common side effects of Adefovir CAS:106941-25-7 include headache, nausea, and fatigue. However, these side effects are usually mild and transient.

Q: Can Adefovir CAS:106941-25-7 be used in pregnant women?

A: Adefovir CAS:106941-25-7 is not recommended for use in pregnant women unless the potential benefits outweigh the risks. It is essential to consult with a healthcare professional before starting treatment.

Conclusión

Adefovir CAS:106941-25-7 is a vital antiviral medication used in the treatment of chronic hepatitis B virus (HBV) infection and other viral infections. This guide provides a comprehensive overview of the product, including its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By understanding the product's benefits and limitations, users can make informed decisions regarding its use.